Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival

被引:100
|
作者
Ahmad, Faraz S. [1 ,2 ]
Ning, Hongyan [1 ]
Rich, Jonathan D. [2 ]
Yancy, Clyde W. [2 ]
Lloyd-Jones, Donald M. [1 ,2 ]
Wilkins, John T. [1 ,2 ]
机构
[1] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Med Cardiol, Chicago, IL 60611 USA
关键词
epidemiology; heart failure; prevention; risk factors; LIFETIME RISK; CARDIOVASCULAR-DISEASE; POPULATION; CORONARY; PROGRESSION; PREDICTORS; PROFILE; BURDEN; HEALTH; IMPACT;
D O I
10.1016/j.jchf.2016.08.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to quantify the relationship between the absence of heart failure risk factors in middle age and incident heart failure, heart failure-free survival, and overall survival. BACKGROUND Quantification of years lived free from heart failure in the context of risk factor burden in mid-life may improve risk communication and prevention efforts. METHODS We conducted a pooled, individual-Level analysis sampling from communities across the United States as part. of 4 cohort studies: the Framingham Heart, Framingham Offspring, Chicago Heart Association Detection Project in Industry, and ARIC (Atherosclerosis Risk In Communities) studies. Participants with and without hypertension (blood pressure >= 140/90 mm Hg or treatment), obesity (body mass index >= 30 kg/m(2)), or diabetes (fasting glucose >= 126 mg/dl or treatment), and combinations of these factors, at index ages of 45 years and 55 years through 95 years. Competing risk-adjusted Cox models, a modified Kaplan-Meier estimator, and Irwin's restricted mean were used to estimate the association between the absence of risk factors at mid-life and incident heart failure, heart failure-free survival, and overall survival. RESULTS For participants at age 45 years, over 516,537 person-years of follow-up, 1,677 incident heart failure events occurred. Men and women with no risk factors, compared to those with all 3, had 73% to 85% lower risks of incident heart failure. Men and women without hypertension, obesity, or diabetes at age 45 years lived on average 34.7 years and 38.0 years without incident heart failure, and they lived on average an additional 3 years to 15 years longer free of heart failure than those with 1, 2, or 3 risk factors. Similar trends were seen when stratified by race and at index age 55 years. CONCLUSIONS Prevention of hypertension, obesity, and diabetes by ages 45 years and 55 years may substantially prolong heart failure-free survival, decrease heart failure-related morbidity, and reduce the public health impact of heart failure. (C) 2016 by the American College of Cardiology Foundation.
引用
收藏
页码:911 / 919
页数:9
相关论文
共 50 条
  • [22] Obesity and cognitive dysfunction in heart failure: The role of hypertension, type 2 diabetes, and physical fitness
    Alosco, Michael L.
    Spitznagel, Mary Beth
    Cohen, Ronald
    Sweet, Lawrence H.
    Josephson, Richard
    Hughes, Joel
    Rosneck, Jim
    Gunstad, John
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2015, 14 (04) : 334 - 341
  • [23] Absence of obesity paradox for acute heart failure with diabetes, whereas evidence of obesity paradox for acute heart failure without diabetes
    Harada, KKazumasa
    Sakai, T.
    Kohsaka, S.
    Sato, N.
    Takagi, A.
    Miyamoto, T.
    Iida, K.
    Tanimoto, S.
    Nagao, K.
    Takayama, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 253 - 253
  • [24] A Predictive Score for Failure-Free Survival in Persons with Chronic Myeloid Leukemia Receiving Imatinib
    Zhang, Xiaoshuai
    Huang, Xiaojun
    Gale, Robert Peter
    Jiang, Qian
    BLOOD, 2021, 138
  • [25] DIABETES EPISODIC HYPERTENSION AND HEART FAILURE - IS IT PHEOCHROMACYTOMA
    COPELAND, RB
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1969, 208 (02): : 366 - &
  • [26] Hematopoietic Stem Cell Transplantation for Aplastic Anemia in Children: Better Failure-Free and GVHD-Free/Failure-Free Survival With Fludarabine-Based Conditioing: Single Institution Study on 43 Cases
    Kook, H.
    Im, S. H.
    Kim, B. R.
    Yoon, B. A.
    Park, S. M.
    Baek, H. J.
    Kim, H. J.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S320 - S320
  • [27] Engineering the Failure-Free Lifetime for Cu Vias
    Hall, Gavin D. R.
    Allman, Derryl D. J.
    Eda, Masaichi
    Long, Thomas F., II
    2016 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM (IRPS), 2016,
  • [28] MEAN TIME TO ACHIEVE A FAILURE-FREE REQUIREMENT
    ANGUS, JE
    SCHAFER, RE
    IEEE TRANSACTIONS ON RELIABILITY, 1985, 34 (02) : 179 - 183
  • [29] MULTIPLIER ESTIMATES OF THE PROBABILITY OF FAILURE-FREE OPERATION
    BELYAYEV, YK
    SOVIET JOURNAL OF COMPUTER AND SYSTEMS SCIENCES, 1985, 23 (05): : 107 - 121
  • [30] Hodgkin lymphoma - closer to failure-free treatment
    Paszkiewicz-Kozik, Ewa
    Walewski, Jan
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (04): : 199 - 210